USPTO Examiner MEADOWS CHRISTINA L - Art Unit 1663

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18650291INSECTICIDAL PROTEINS AND METHODS FOR THEIR USEApril 2024March 2026Allow2210NoNo
18584016Wheat Variety G18C2097February 2024February 2026Allow2410NoNo
18436630SOYBEAN CULTIVAR 20372402February 2024February 2026Allow2410NoNo
18436876DIPLOID SELF-COMPATIBLE POTATO PLANT OR PART THEREOFFebruary 2024September 2025Abandon1920NoNo
18419828SOYBEAN LINE EC2020188January 2024March 2026Allow2511NoNo
18406748SOYBEAN CULTIVAR 27330335January 2024February 2026Allow2510NoNo
18389772PLANTS AND SEEDS OF HYBRID CORN VARIETY CH010541December 2023February 2026Allow2610NoNo
18534647PLANTS AND SEEDS OF CORN VARIETY CV964538December 2023January 2026Allow2510NoNo
18534642PLANTS AND SEEDS OF CORN VARIETY CV622763December 2023January 2026Allow2510NoNo
18534649PLANTS AND SEEDS OF CORN VARIETY CV967679December 2023January 2026Allow2510NoNo
18513363SOYBEAN VARIETY 01106511November 2023January 2026Allow2610NoNo
18513412SOYBEAN VARIETY 01098318November 2023January 2026Allow2610NoNo
18511943SOYBEAN VARIETY 01098358November 2023January 2026Allow2610NoNo
18289268USE OF ATTENUATED TOMATO BROWN RUGOSE FRUIT VIRUS FOR PROTECTING CROPS AGAINST SAME VIRUSNovember 2023December 2025Abandon2511NoNo
18497216VARIETY CORN LINE LRFF7060ZLOctober 2023March 2026Allow2920NoNo
18492644SOYBEAN CULTIVAR 21180343October 2023October 2025Allow2410NoNo
18240270SOYBEAN VARIETY '10020889166'August 2023February 2026Allow3011NoNo
18271994An embryo rescue and in vitro herbicidal selection method for sunflowerJuly 2023February 2026Abandon3121NoNo
18259006POLYNUCLEOTIDES AND METHODS FOR TRANSFERRING RESISTANCE TO ASIAN SOYBEAN RUSTJune 2023November 2025Allow2911NoNo
18037710PLANT CELL CHROMOSOME DOUBLING BY APPLICATION OF ELECTROMAGNETIC FIELDMay 2023December 2025Allow3111NoNo
18035906PARTHENOCARPIC WATERMELON PLANTSMay 2023February 2026Allow3320NoNo
18033170METHODS FOR PRODUCING VANILLA PLANTS WITH IMPROVED FLAVOR AND AGRONOMIC PRODUCTIONApril 2023April 2025Abandon2401NoNo
18031322PARTHENOCARPIC WATERMELON PLANTSApril 2023February 2026Allow3420YesNo
18184404ENDOCARP-SPECIFIC PROMOTER AND USES THEREOFMarch 2023April 2024Allow1310NoNo
18025219STEM RUST RESISTANCE GENEMarch 2023January 2026Allow3521NoNo
18023815Disease Resistant Squash PlantsFebruary 2023March 2025Allow2501YesNo
18173947PROMOTER ELEMENTS FOR IMPROVED POLYNUCLEOTIDE EXPRESSION IN PLANTSFebruary 2023October 2025Abandon3211NoNo
18005453CANNABIS WITH ALTERED CANNABINOID CONTENTJanuary 2023January 2025Abandon2401NoNo
18004060R GENE FOR CONTROLLING MATCHING OF SOYBEAN-RHIZOBIUM, PROTEIN AND USE THEREOFDecember 2022October 2025Allow3421NoNo
18065814Cytoplasmic Male-Sterile Rudbeckia Plants and a Method of ProductionDecember 2022November 2025Allow3521NoNo
18073423Plants and Seeds of Hybrid Corn Variety CH010433December 2022April 2025Allow2910NoNo
18072673Plants and Seeds of Hybrid Corn Variety CH010378November 2022June 2025Allow3110NoNo
18072679Plants and Seeds of Corn Variety CV850339November 2022July 2025Allow3210NoNo
18071596Plants and Seeds of Hybrid Corn Variety CH010391November 2022June 2025Allow3110NoNo
17924935METHOD FOR IDENTIFICATION, DISTINCTION AND SELECTION OF PLANTS OF THE GLYCINE GENUS, RESISTANT OR SUSCEPTIBLE TO TARGET SPOT CAUSED BY THE FUNGUS CORYNESPORA CASSIICOLA , METHOD FOR INTROGRESSION INTO PLANTS OF THE GLYCINE GENUS OF ALLELES OF RESISTANCE TO TARGET SPOT CAUSED BY THE FUNGUS CORYNESPORA CASSIICOLA, NUCLEIC ACID MOLECULE AND ITS USE, DETECTION KIT, METHOD FOR GENOTYPING TARGET SPOT-RESISTANT GLYCINE TARGET PLANTS AND TARGET SPOT-RESISTANT GLYCINE PLANTSNovember 2022December 2025Abandon3711NoNo
17923463EXPRESSION OF IPT7 FROM TSS PROMOTER INCREASES ROOT MASS AND CARBON SEQUESTRATIONNovember 2022June 2025Allow3110YesNo
17995929CUCUMBER PLANT HABITOctober 2022October 2025Abandon3721NoNo
17995707PLANT PATHOGEN EFFECTOR AND DISEASE RESISTANCE GENE IDENTIFICATION, COMPOSITIONS, AND METHODS OF USEOctober 2022August 2025Allow3411NoNo
17912835METHOD FOR MASS PRODUCTION OF TARGET PROTEIN IN PLANTSeptember 2022April 2025Allow3011YesNo
17908579SOYBEAN PROMOTERS AND USES THEREOFSeptember 2022September 2024Allow2411YesNo
17822822MODIFICATION OF UBIQUITIN BINDING PEPTIDASE GENES IN PLANTS FOR YIELD TRAIT IMPROVEMENTAugust 2022March 2025Allow3011YesNo
17904343GENETICALLY ENGINEERED PLANTS THAT EXPRESS 6-PHOSPHOGLUCONATE DEHYDRATASE AND/OR 2-KETO-3-DEOXY-6-PHOSPHOGLUCONATE ALDOLASEAugust 2022March 2025Abandon3111NoNo
17760160METHODS OF CONTROLLING GRAIN SIZE AND WEIGHTAugust 2022October 2025Abandon3921YesNo
17874409METHOD FOR IMPROVING SOYBEAN HYBRID YIELDJuly 2022March 2025Abandon3211NoNo
17789347IN VITRO DIRECT REGENERATION OF POLYPLOID CANNABIS PLANTSJune 2022December 2024Abandon2910NoNo
17849538SYNTHETIC TOOLKIT FOR PLANT TRANSFORMATIONJune 2022October 2024Abandon2801NoNo
17842515PEST AND PATHOGEN RESISTANCE IN PLANTSJune 2022July 2024Abandon2510NoNo
17784515COMPOSITIONS AND METHODS FOR TRANSGENIC CROPS RESISTANT TO THAXTOMINSJune 2022February 2025Allow3220YesNo
17831546METHOD FOR IDENTIFYING WHETHER A DIPLOID POTATO IS SELF-COMPATIBLEJune 2022March 2025Allow3321YesNo
17781904REGULATORY NUCLEIC ACID MOLECULES FOR ENHANCING GENE EXPRESSION IN PLANTSJune 2022February 2025Allow3221NoNo
17776466TRANSGENIC PLANTS FROM THE BRASSICA spp. GENUS WITH MYCORRHIZATION CAPACITY AND HAVING AN INCREASED PRODUCTIVITYMay 2022July 2024Abandon2601NoNo
17773236USE OF miRNA408 IN REGULATION OF CADMIUM ACCUMULATION IN CROPApril 2022January 2025Abandon3211NoNo
17766528Cannabis Ubiquitin PromoterApril 2022September 2024Allow2910YesNo
17753918LOW PHYTOESTROGEN SOYBEAN BASED ON GENE EDITINGMarch 2022March 2026Abandon4831NoNo
17640963PROMOTERS FOR REGULATION OF GENE EXPRESSION IN PLANTSMarch 2022May 2024Allow2611YesNo
17632374FLOWERING TIME GENES AND METHODS OF USEFebruary 2022October 2024Abandon3311NoNo
17597717USE OF SOYBEAN BROAD-SPECTRUM DISEASE RESISTANCE RELATED GENEJanuary 2022July 2024Allow3011YesNo
175514553'UTR SEQUENCE FOR TRANSGENE EXPRESSIONDecember 2021September 2024Allow3310NoNo
17534479ENGINEERING, PRODUCTION AND CHARACTERIZATION OF PLANT PRODUCED, SOLUBLE HUMAN ANGIOTENSIN CONVERTING ENZYME-2 AS A THERAPEUTIC TARGET IN COVID-19November 2021June 2024Abandon3101NoNo
17614117DOWNY MILDEW RESISTANT MELON PLANTSNovember 2021June 2025Allow4321YesYes
17610529DROUGHT TOLERANCE IN CORNNovember 2021December 2025Abandon5041NoNo
17609966REGULATORY NUCLEIC ACID MOLECULES FOR ENHANCING GENE EXPRESSION IN PLANTSNovember 2021January 2025Allow3821YesNo
17283042INSECTICIDAL PROTEINS AND METHODS FOR THEIR USEApril 2021July 2024Abandon3911NoNo
17280114PLANT SERINE PROTEASESMarch 2021October 2025Allow5532YesNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner MEADOWS, CHRISTINA L.

Strategic Value of Filing an Appeal

Total Appeal Filings
1
Allowed After Appeal Filing
1
(100.0%)
Not Allowed After Appeal Filing
0
(0.0%)
Filing Benefit Percentile
95.8%
Higher than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 100.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the top 25% across the USPTO, indicating that filing appeals is particularly effective here. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Strategic Recommendations

Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Examiner MEADOWS, CHRISTINA L - Prosecution Strategy Guide

Executive Summary

Examiner MEADOWS, CHRISTINA L works in Art Unit 1663 and has examined 7 patent applications in our dataset. With an allowance rate of 57.1%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 39 months.

Allowance Patterns

Examiner MEADOWS, CHRISTINA L's allowance rate of 57.1% places them in the 17% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by MEADOWS, CHRISTINA L receive 1.86 office actions before reaching final disposition. This places the examiner in the 44% percentile for office actions issued. This examiner issues fewer office actions than average, which may indicate efficient prosecution or a more lenient examination style.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by MEADOWS, CHRISTINA L is 39 months. This places the examiner in the 25% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a +75.0% benefit to allowance rate for applications examined by MEADOWS, CHRISTINA L. This interview benefit is in the 99% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 25.0% of applications are subsequently allowed. This success rate is in the 38% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 66.7% of cases where such amendments are filed. This entry rate is in the 90% percentile among all examiners. Strategic Recommendation: This examiner is highly receptive to after-final amendments compared to other examiners. Per MPEP § 714.12, after-final amendments may be entered "under justifiable circumstances." Consider filing after-final amendments with a clear showing of allowability rather than immediately filing an RCE, as this examiner frequently enters such amendments.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 200.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 93% percentile among all examiners. Strategic Recommendation: Pre-appeal conferences are highly effective with this examiner compared to others. Before filing a full appeal brief, strongly consider requesting a PAC. The PAC provides an opportunity for the examiner and supervisory personnel to reconsider the rejection before the case proceeds to the PTAB.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 100.0% of appeals filed. This is in the 87% percentile among all examiners. Of these withdrawals, 100.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner frequently reconsiders rejections during the appeal process compared to other examiners. Per MPEP § 1207.01, all appeals must go through a mandatory appeal conference. Filing a Notice of Appeal may prompt favorable reconsideration even before you file an Appeal Brief.

Petition Practice

When applicants file petitions regarding this examiner's actions, 0.0% are granted (fully or in part). This grant rate is in the 0% percentile among all examiners. Strategic Note: Petitions are rarely granted regarding this examiner's actions compared to other examiners. Ensure you have a strong procedural basis before filing a petition, as the Technology Center Director typically upholds this examiner's decisions.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 2% percentile). This examiner rarely makes examiner's amendments compared to other examiners. You should expect to make all necessary claim amendments yourself through formal amendment practice.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 3% percentile). This examiner rarely issues Quayle actions compared to other examiners. Allowances typically come directly without a separate action for formal matters.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prepare for rigorous examination: With a below-average allowance rate, ensure your application has strong written description and enablement support. Consider filing a continuation if you need to add new matter.
  • Prioritize examiner interviews: Interviews are highly effective with this examiner. Request an interview after the first office action to clarify issues and potentially expedite allowance.
  • Consider after-final amendments: This examiner frequently enters after-final amendments. If you can clearly overcome rejections with claim amendments, file an after-final amendment before resorting to an RCE.
  • Request pre-appeal conferences: PACs are highly effective with this examiner. Before filing a full appeal brief, request a PAC to potentially resolve issues without full PTAB review.
  • Appeal filing as negotiation tool: This examiner frequently reconsiders rejections during the appeal process. Filing a Notice of Appeal may prompt favorable reconsideration during the mandatory appeal conference.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.